ArticleThe Prostate2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidates.
Gabriele Sorce et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it